The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting Disorders
Abstract
Fibroblast growth factor 23 (FGF23) is a recently characterized protein likely involved in the regulation of serum phosphate homeostasis. Increased circulating levels of FGF23 have been reported in patients with renal phosphate-wasting disorders, but it is unclear whether FGF23 is the direct mediator responsible for the decreased phosphate transport at the proximal renal tubules and the altered vitamin D metabolism associated with these states. To examine this question, we generated transgenic mice expressing and secreting from the liver human FGF23 (R176Q), a mutant form that fails to be degraded by furin proteases. At 1 and 2 months of age, mice carrying the transgene recapitulated the biochemical (decreased urinary phosphate reabsorption, hypophosphatemia, low serum 1,25-dihydroxyvitamin D3) and skeletal (rickets and osteomalacia) alterations associated with these disorders. Unexpectantly, marked changes in parameters of calcium homeostasis were also observed, consistent with secondary hyperparathyroidism. Moreover, in the kidney the anticipated alterations in the expression of hydroxylases associated with vitamin D metabolism were not observed despite the profound hypophosphatemia and increased circulating levels of PTH, both major physiological stimuli for 1,25-dihydroxyvitamin D3 production. Our findings strongly support the novel concept that high circulating levels of FGF23 are associated with profound disturbances in the regulation of phosphate and vitamin D metabolism as well as calcium homeostasis and that elevated PTH levels likely also contribute to the renal phosphate wasting associated with these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“suggesting that in the current study elevated iFGF23 did not inhibit PTH secretion but rather PTH stimulated iFGF23, eventually to lower plasma Pi [4, 39].”
From Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels (2025) · cites this paper as [4]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K., Evans, W. E., O'Riordan, J., Speer, M., Econs, M., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,467
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.101545198 · Cited by 1,391
Shimada, T., Kakitani, M., Yamazaki, Y., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419081 · Cited by 1,368
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A. J., Lehrach, H. R., Rowe, P. S., Goulding, J. N., Summerfield, T. C., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,095
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R. J., Larsson, T. E., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 904
NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION
Walton, R. J., & Bijvoet, O. L. M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92736-1 · Cited by 892
Yamazaki, Y., Okazaki, R., Shibata, M., Hasegawa, Y., Satoh, K., Tajima, T., Takeuchi, Y., Fujita, T., Nakahara, K., Yamashita, T., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021105 · Cited by 670
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
Riminucci, M., Collins, M. T., Fedarko, N. S., Cherman, N., Corsi, A., White, K. E., Waguespack, S. G., Gupta, A., Hannon, T. S., Econs, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18399 · Cited by 656
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–329 of 329
Inglese, C. N. (2016) · QSpace (Queen's University Library)
Idris, S., Ebeid, A., Hashad, D. I., Sadaka, M. A., Elshafie, M., & Sakr, M. (2016) · Egyptian Journal of Obesity Diabetes and Endocrinology · doi:10.4103/2356-8062.197572
Rafi, S. K., & Razzaque, M. S. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6566-3_3
Quarles, L. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00047-1 · Cited by 1
Hereditary tubulopathies including the associated bone disease
Ryznychuk, М. О., Хмара, Т. В., Kryvchanska, M. I., & Zamorskii, І. І. (2018) · Regulatory Mechanisms in Biosystems · doi:10.15421/021805
A critical review of the assessment of Vitamin D status
Chausmer, A. B. (2018) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2018.06.00185
Endocrine Effects of Space Flight
Hammond, T. G., & Birdsall, H. H. (2018) · Springer eBooks · doi:10.1007/978-3-319-50909-9_6-1
Asowata, E. O. (2019) · UCL Discovery (University College London)
Tebben, P. J., Berndt, T. J., & Kumar, R. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50018-5
Parathyroid hormone and fetal growth in a pregnancy cohort in Dhaka, Bangladesh
Qamar, H. (2018) · TSpace (University of Toronto)
Tebben, P. J., & Kumar, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00010-1
Role of the Kidney in Calcium and Phosphorus Homeostasis
Pal, A., & Kaskel, F. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00106-2
Yang, Y., Wang, Y., Shen, Y., Liu, M., Dai, S., Wang, X., & Liu, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.792183
Wagner, C. A. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1103614.559697
Tebben, P. J., Berndt, T. J., & Kumar, R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50017-2
Jakob, F. J., Ebert, R., & Seufert, J. (2006) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003934.01
25-Hydroxyvitamin D-1α- Hydroxylase: Studies in Mouse Models and Implications for Human Disease
Goltzman, D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-303-9_39
Self-citationPiret, S. E., & Thakker, R. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00007-1
Clinical disorders of phosphate homeostasis
Liu, E. S., & Jüppner, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00014-8
Understanding vitamin D from mouse knockout models
Goltzman, D., Karapalis, A. C., Kremer, R. B., & Miao, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00010-6
Self-citationLines, K. E., & Thakker, R. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00036-0
Whyte, M. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00026-8
Vélayoudom‐Céphise, F. (2012) · doi:10.70675/25757912z8b37z4273zb275zcc29c39176f2
Clinical disturbances of phosphate homeostasis
Kritmetapak, K., Berndt, T. J., & Kumar, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-815389-5.00011-3
Bone matrix mineralization: Molecular regulation, hierarchical structure, and emerging paradigms
Murshed, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26739-0.00012-0
Fibroblast Growth Factor 23 as a Potential Target for Treatment
MD, M. F. L., & PhD Zhousheng Xiao, M. D. (2025) · Nephrology - Open Journal · doi:10.17140/npoj.2025.v9.i01.pp01-06.2212
FGF23 - a possible Phosphatonin
Marsell, R. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Hendy, G. N., Kremer, R. B., & Goltzman, D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10033-2
Self-citation
Metadata
- Authors
- Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C.
- Affiliations
- Jewish General Hospital (CA)
- McGill University Health Centre (CA)
- Corresponding author
- Karaplis, Andrew C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-11-01
- Volume
- 145
- Issue
- 11
- Pages
- 5269-5279
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2144414222
- Cited by
- 329
- References
- 55
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 3 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 9 · 2019: 11 · 2018: 17 · 2017: 12 · 2016: 25 · 2015: 11 · 2014: 11 · 2013: 13 · 2012: 33
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute
- Canadian Arthritis Network
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Nephrology › Renal function and acid-base balance
- Keywords
- fibroblast growth factor 23, parathyroid hormone, renal phosphate wasting, hypophosphatemia, vitamin D metabolism, 1,25-dihydroxyvitamin D3, secondary hyperparathyroidism, calcium homeostasis, osteomalacia, rickets, transgenic mice, furin protease
- MeSH terms
- Fibroblast Growth Factor-23, Animals, Bone and Bones, Calcium, Female, Fibroblast Growth Factors, Carcinoma, Hepatocellular, Humans, Hypophosphatemia, Familial, Kidney Tubules, Proximal, Male, Mice, Transgenic, Osteomalacia, Parathyroid Hormone, Phosphates, Pregnancy, Vitamin D, Gene Expression, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
